News, markets, and regulation in Europe, Asia, and South America.
September 9, 2009
By:Sarah Houlton
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?
 |
July 8, 2009
By:Sarah Houlton
UK Health Institute leaves guidance unchanged in case against Eisai and Pfizer; more research on NICE methodology needed.
|
June 17, 2009
Pharma is wrestling to understand the emerging markets will be the engine of growth for future sales.
|
April 1, 2009
A new report by the Royal College of Physicians breaks down the reasons why patients are disillusioned about access to medicines, and documents a steady growth in the lack of trust between industry and the NHS. More importantly, it gives recommendations on how to solve the problems.
|
February 1, 2009
By:Sarah Houlton
EC proposal loosens restrictions on drug packaging and information dissemination.
|
December 1, 2008
By:Sarah Houlton
The new EU directive looks to reduce, refine, and eventually replace animal testing
|
November 1, 2008
By:Sarah Houlton
In Europe, it's different strokes for different folks at the top regulatory agencies
|
October 1, 2008
By:Sarah Houlton
Tensions mount as stakeholders in the UK health industry attempt to work out drug cost problems
|
September 1, 2008
By:Sarah Houlton
In order to take a big step forward, GSK looks to employ smaller licensing deals and business units
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Super Reps book trilogy by Dr. Lou Sawaya MD, MBA
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
Conducting clinical trials in emerging regions can give you the edge. Five Quintiles experts share their insights into navigating the global regulatory landscape.